94 related articles for article (PubMed ID: 27269712)
1. Differential modulation of the lipid metabolism as a model for cellular resistance to fumonisin B1-induced cytotoxic effects in vitro.
Riedel S; Abel S; Burger HM; van der Westhuizen L; Swanevelder S; Gelderblom WC
Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():39-51. PubMed ID: 27269712
[TBL] [Abstract][Full Text] [Related]
2. Modulation of key lipid raft constituents in primary rat hepatocytes by fumonisin B
Burger HM; Abel S; Gelderblom WCA
Food Chem Toxicol; 2018 May; 115():34-41. PubMed ID: 29510220
[TBL] [Abstract][Full Text] [Related]
3. Fumonisin B
Riedel S; Abel S; Burger HM; Swanevelder S; Gelderblom WCA
Biochim Biophys Acta Biomembr; 2024 Jun; 1866(5):184310. PubMed ID: 38479610
[TBL] [Abstract][Full Text] [Related]
4. Effect of fumonisin B1 on protein and lipid synthesis in primary rat hepatocytes.
Gelderblom WC; Smuts CM; Abel S; Snyman SD; Cawood ME; van der Westhuizen L; Swanevelder S
Food Chem Toxicol; 1996 Apr; 34(4):361-9. PubMed ID: 8641662
[TBL] [Abstract][Full Text] [Related]
5. Induction of an altered lipid phenotype by two cancer promoting treatments in rat liver.
Riedel S; Abel S; Swanevelder S; Gelderblom WC
Food Chem Toxicol; 2015 Apr; 78():96-104. PubMed ID: 25656646
[TBL] [Abstract][Full Text] [Related]
6. Effect of fumonisin B1 on the levels and fatty acid composition of selected lipids in rat liver in vivo.
Gelderblom WC; Smuts CM; Abel S; Snyman SD; Van der Westhuizen L; Huber WW; Swanevelder S
Food Chem Toxicol; 1997 Jul; 35(7):647-56. PubMed ID: 9301647
[TBL] [Abstract][Full Text] [Related]
7. Altered lipid parameters in hepatic subcellular membrane fractions induced by fumonisin B1.
Burger HM; Abel S; Snijman PW; Swanevelder S; Gelderblom WC
Lipids; 2007 Apr; 42(3):249-61. PubMed ID: 17393230
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol alters the lipid composition, metabolism and peroxide level in senescent rat hepatocytes.
Momchilova A; Petkova D; Staneva G; Markovska T; Pankov R; Skrobanska R; Nikolova-Karakashian M; Koumanov K
Chem Biol Interact; 2014 Jan; 207():74-80. PubMed ID: 24183824
[TBL] [Abstract][Full Text] [Related]
9. The aflatoxin B
Mary VS; Arias SL; Otaiza SN; Velez PA; Rubinstein HR; Theumer MG
Environ Toxicol; 2017 Jun; 32(6):1711-1724. PubMed ID: 28181396
[TBL] [Abstract][Full Text] [Related]
10. Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.
Gelderblom WC; Moritz W; Swanevelder S; Smuts CM; Abel S
Lipids; 2002 Sep; 37(9):869-77. PubMed ID: 12458622
[TBL] [Abstract][Full Text] [Related]
11. Regulation of fatty acid biosynthesis as a possible mechanism for the mitoinhibitory effect of fumonisin B1 in primary rat hepatocytes.
Gelderblom WC; Abel S; Smuts CM; Swanevelder S; Snyman SD
Prostaglandins Leukot Essent Fatty Acids; 1999 Oct; 61(4):225-34. PubMed ID: 10574646
[TBL] [Abstract][Full Text] [Related]
12. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
[TBL] [Abstract][Full Text] [Related]
13. Effects of oxidative stress on glycerolipid acyl turnover in rat hepatocytes.
Girón-Calle J; Schmid PC; Schmid HH
Lipids; 1997 Sep; 32(9):917-23. PubMed ID: 9307931
[TBL] [Abstract][Full Text] [Related]
14. Magnolol ameliorates fumonisin B
Wang X; Cheng D; Liu L; Yu H; Wang M
Chemosphere; 2024 Jul; 359():142300. PubMed ID: 38729444
[TBL] [Abstract][Full Text] [Related]
15. Fumonisin B
Szabó A; Fébel H; Ali O; Kovács M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2019 Nov; 36(11):1722-1739. PubMed ID: 31437116
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress-mediated autophagy activation attenuates fumonisin B1 induced hepatotoxicity in vitro and in vivo.
Singh MP; Kang SC
Food Chem Toxicol; 2017 Dec; 110():371-382. PubMed ID: 29097114
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
18. Changes in essential fatty acid patterns associated with normal liver regeneration and the progression of hepatocyte nodules in rat hepatocarcinogenesis.
Abel S; Smuts CM; de Villiers C; Gelderblom WC
Carcinogenesis; 2001 May; 22(5):795-804. PubMed ID: 11323400
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of fumonisin B
Szabó A; Szabó-Fodor J; Fébel H; Mézes M; Bajzik G; Kovács M
Physiol Int; 2016 Sep; 103(3):321-333. PubMed ID: 28229635
[TBL] [Abstract][Full Text] [Related]
20. Elevated whole muscle phosphatidylcholine: phosphatidylethanolamine ratio coincides with reduced SERCA activity in murine overloaded plantaris muscles.
Fajardo VA; Mikhaeil JS; Leveille CF; Tupling AR; LeBlanc PJ
Lipids Health Dis; 2018 Mar; 17(1):47. PubMed ID: 29534725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
